• Rehabilitation and cross-over design: an evaluation on Medline and Embase
• Rehabilitation in Africa - Building capacity in clinical practice guidelines development and use
• Rehabilitation interventions in randomized controlled trials for low back pain: are they statistically significant and clinically relevant?
• Rehabilitation practitioners' perceptions of clinical practice guidelines for stroke managment when working in rural primary care in South Africa
• Relationship between collected and published outcomes: a case of IPD meta-analysis on the effect of diet and lifestyle in pregnancy
• Relationship between global burden of disease and quantity of published randomized controlled trials
• Relationship between the description of primary outcomes and significance of the results in trials with diet and lifestyle in pregnancy
• Relative paucity of high-quality or moderate-quality evidence to inform World Health Organization guidelines on antiretroviral therapy
• Relatively absolute (one size may not fit all)
• Relevance In action: how can Cochrane reviews meet consumers' needs?
• Reliability and applicability of RoB 2: experience within the pilot review “Cannabis and cannabinoids for people with multiple sclerosis”
• Reliability and applicability of the revised Cochrane 'Risk of bias' tool for randomized trials (RoB 2)
• Reliability and feasibility of the Health Evidence™ quality assessment tool for systematic reviews on the effectiveness of public health interventions
• Reliability and validity assessment of a risk-of-bias instrument for non-randomised studies of exposures
• Reliability and validity of instruments measuring research utilization in health care
• Reliability and validity of the Newcastle Ottawa Scale
• Reliability of a Scale for Measuring the Methodological Quality of Clinical Trials
• Reliability of data extraction using manual measurements of published graphs or figures
• Reliability of estimating odds ratios of response and the corresponding standard errors from continuous rating scale scores for meta-analysis: a case study in trials on depression treatment
• Reliability of risk of bias assessments between pairs of reviewers from different centers and reasons for disagreement
• Reliably estimating interactions and subgroup effects in aggregate data meta-analysis
• Relocating a Cochrane entity: the United States Cochrane Center experience
• REMARK Profile Study: reporting of participant flow and events in prognostic studies of tumour markers
• Remote development of a localised package of care to support primary healthcare clinicians in Nigeria: A case study
• Repeated measures meta-analysis of clinical trials
• Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke
• Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up
• Report on the ‘pre’ and ‘post’ peer review questionnaire on ‘assessment and treatment of gonarthrosis’
• Report on The Cochrane Empty Review Project Consensus Meeting: A proposal of empty review reporting guidelines and an invitation for feedback
• Reported estimates of diagnostic accuracy in ophthalmology conference abstracts are not associated with full-text publication
• Reported use and perceptions of value of Cochrane evidence by South African guideline developers
• Reported versus actual analytical methods to handle missing participant data in meta-analysis: a survey of 100 systematic reviews
• Reporting adverse events in reviews and the PRISMA Harms
• Reporting and analysis of missing participant continuous data in randomized controlled trials (LOST-IT-II): a systematic survey
• Reporting and application of minimally important differences in randomized controlled trials evaluating patient reported outcomes: a systematic survey
• Reporting and methodological quality of systematic reviews in the orthopaedic literature
• Reporting and methodological quality of systematic reviews of interventions published in Chinese surgical journals
• Reporting and methods in systematic reviews of comparative accuracy
• Reporting bias and aripiprazole for schizophrenia: new data from unpublished studies
• Reporting bias in clinical trials
• Reporting Bias in Imaging Diagnostic Accuracy Research: Update on Recent Evidence
• Reporting bias in imaging diagnostic accuracy studies: Are studies with positive conclusions or titles submitted and published faster?
• Reporting bias in imaging research: association of diagnostic accuracy estimates in radiology conference abstracts with full-text publication
• Reporting bias in industry-sponsored spinal fusion studies of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2)
• Reporting bias: higher diagnostic accuracy is linked to faster publication in imaging research
• Reporting characteristics and quality of systematic reviews on acupuncture analgesia
• Reporting characteristics of Cochrane Reviews on health policy research
• Reporting characteristics of health policy briefs: a cross-sectional study of briefs in HSE and WHO databases
• Reporting Characteristics of Health Policy Briefs：A cross-sectional study
• Reporting Characteristics of Negative Pressure Wound Therapy Systematic Reviews
• Reporting gap of randomized clinical trials registered in Western Mexico, a cross-sectional study
• Reporting guidelines for qualitative and mixed-method syntheses: contemporary and novel developments
• Reporting guidelines for reporting searches of network meta-analysis are needed
• Reporting guidelines for systematic review protocols
• Reporting health related quality of life in critical care RCTs
• Reporting Items for Practice Guidelines in Healthcare (RIGHT)
• Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA-A statement
• Reporting methodological search filter performance comparisons: a review
• Reporting missing outcome data for participants in randomized trials: a methodological survey of proposed approaches
• Reporting of absolute estimates of effect of patient important benefits and harms in abstracts of systematic reviews
• Reporting of adverse events in systematic reviews
• Reporting of clinical prediction model studies in journal and conference abstracts: TRIPOD for Abstracts
• Reporting of Cochrane Systematic Review protocols with network meta-analyses – a scoping review
• Reporting of conflicts of interest in Cochrane reviews of trials of pharmacological treatments
• Reporting of Drug Trial Funding Sources and Author Financial Conflicts of Interest in Cochrane and non-Cochrane Meta-analyses
• Reporting of effect direction and size in abstracts of systematic reviews
• Reporting of eligibility criteria of participants in randomized trials: comparison between study protocols and journal articles
• Reporting of essential items in comparative accuracy studies: A literature review
• Reporting of financial and non-financial conflicts of interest by authors of 200 Cochrane and non-Cochrane systematic reviews: a methodological survey
• Reporting of financial and non-financial conflicts of interest by authors of 200 randomized controlled trials: a methodological survey
• Reporting of financial and non-financial conflicts of interest by authors of health policy and systems systematic reviews: a methodological survey
• Reporting of harm in randomized controlled trials evaluating pharmacological and nonpharmacological treatments
• Reporting of harms in clinical trials: overview of the adherence to CONSORT (Consolidated Standards of Reporting Trials) Harms 2004
• Reporting of harms in randomized trials of mental health interventions
• Reporting of industry-funded trial outcome data: a comparison of journal publications with confidential individual patient data and clinical study reports
• Reporting of information retrieval in Campbell Systematic Reviews
• Reporting of interim analyses, stopping rules, and data safety and monitoring boards in protocols and publications of discontinued randomized trials
• Reporting of intervention fidelity in systematic reviews of asthma education
• Reporting of interventions: a comparative case study before and after the publication of the extended CONSORT guidelines for reporting non-pharmacological trials
• Reporting of ITT analysis in reproductive studies
• Reporting of meta-analyses and systematic reviews of screening tests in China
• Reporting of missing data and protocol deviation in the description of intention to treat is inconsistent in randomized controlled trials.
• Reporting of non-pharmacological treatment interventions: an extension of the CONSORT statement
• Reporting of outcomes in systematic reviews: comparison of protocols and published systematic reviews
• Reporting of participant flow diagrams in published reports of randomized trials
• Reporting of perinatal mortality and its components in Cochrane reviews: still room for improvement?
• Reporting of randomisation in randomised-controlled trials on traditional Chinese medicine: A comparison of three Chinese medicine journals
• Reporting of randomized clinical trials discontinued due to poor recruitment: a literature review
• Reporting of Risk of Bias 2 (RoB2) in Cochrane protocols and reviews
• Reporting of systematic reviews that synthesize studies of prevalence: Assessment of 1150 reviews using the PRISMA 2009 guideline
• Reporting of the role of the expert searcher in Cochrane reviews
• Reporting of the Search for Studies, the Format of Study Identifiers, and the Format of References in Cochrane Reviews
• Reporting of updating process in updated clinical guidelines: A systematic assessment
• Reporting on heath-related quality of life in Cochrane reviews - a challenge for authors?
• Reporting on the quality of randomised controlled trials in prehospital care
• Reporting quality and its influencing factors in randomized controlled trials of traditional Chinese medicine for cancer
• Reporting quality appraisal of clinical practice guidelines on gastric cancer
• Reporting quality appraisal of clinical practice guidelines on pancreatic cancer
• Reporting quality of case series using computer tomography in patients with coronavirus disease 2019
• Reporting quality of continuous quality-improvement studies in the nursing field published in China
• Reporting quality of randomized controlled trials of botanical medicines
• Reporting quality of randomized controlled trials on gastric cancer treated with traditional Chinese medicine published in Chinese journals
• Reporting quality of titles and abstract in retrospective database studies assessing drug effects
• Reporting standard for qualitative research: A good or a bad idea? Preliminary results from a Delphi study
• Reporting the Number Needed to Treat (NNT): a systematic review of randomized controlled trials where the outcome is time to an event
• Reporting, dealing with, and judging risk of bias associated with missing participant data in systematic reviews: a methodological survey
• Reporting, dealing with, and judging risk of bias associated with missing participant data in systematic reviews: a methodological survey
• Reporting, handling, and judging risk of bias associated with missing participant data in systematic reviews
• Reporting, presentation and wording of recommendations in clinical practice guidelines
• Reports of controlled trials from EMBASE: an important contribution to The Cochrane Controlled Trials Register
• Reports on animal experiments involving neoplasms in Chinese Journals: adherence to ARRIVE guidelines
• Representation of older adults, women, and ethnic minorities in published randomized trials of drug therapy for type 2 diabetes
• Representation of patients in receipt of disability benefits among trials of therapy for fibromyalgia
• Reproducibility in Systematic Reviews used to Inform Clinical Practice Guidelines
• Reproducibility of Grading of Recommendations Assessment, Development and Evaluation (GRADE) factors on the strength of recommendations: an empirical assessment
• Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies
• Repurposing Cochrane reviews for a community health information project in Sierra Leone: Malaria prevention
• Requirements of the core clinical journals for authors’ disclosure of financial and non-financial conflicts of interest: a cross sectional study
• Research activities of Evidence-Based Medicine (EBM) in China: a survey of the accepted abstracts of the Eighth Asia-Pacific Conference on EBM
• Research capacity building for Chinese medical practitioners in China: a questionnaire survey
• Research Implications From Cochrane Reviews - what happens to them?
• Research integrity in low- and middle-income countries: Systematic review of prevalence of poor authorship practice, plagiarism and other misconduct
• Research issues in the evaluation and design of interventions to improve outcomes for patients with multimorbidity
• Research networks, are they worth the effort? Experiences of establishing and running an evidence-synthesis network in northwest England
• Research priority setting exercises: how to reach and address needs of disadvantaged groups
• Research priority setting that inform or use systematic reviews
• Research synthesis priorities and guideline development: Linking evidence synthesis production to evidence needs
• Research synthesis to help going from evidence to decision: a practical application of the GRADE/DECIDE Evidence to Decision Framework
• Research trends and Hotspots analysis of multiple sclerosis diagnosis from 2010 to 2019: a bibliometric analysis
• Research waste caused by symptom-based eligibility: a systematic review of Cochrane reviews and their component trials
• Reserpine for Hypertension
• Residual confounding a criterion for assessing quality of randomized trials
• Resource se compared to evidence of effectiveness as an indirect measure of clinical quality and a basis for improvement
• Resources to improve accessibility of systematic review evidence for decision-makers: a systematic scoping review
• Responses to a systematic review
• Responsible research: trends over time in randomized clinical trials
• Responsiveness: A unique psychometric property to consider in evidence-based practice
• Restricting abstracts of Cochrane Reviews: a pragmatic solution
• Results from an exemplar realist review of advocacy interventions for abused women
• Results from Cochrane’s living systematic review pilot
• Results from RCTs and systematic reviews: to whom do they apply?
• Results in systematic reviews of anaesthesia interventions that are reported as statistically significant often contain risk of type I error greater than 5%
• Results of an online survey evaluating reasons for retrospective trial registration and mechanisms to increase prospective registration compliance
• Results of the pilot mentoring programme for Managing Editors
• Retention policies for health workers in rural and remote areas: an overview of reviews
• Rethinking communication – Integrating storytelling for stakeholder engagement in evidence synthesis
• Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
• Rethinking the content of questionnaires when assessing barriers to guideline implementation: a scoping review
• Rethinking Trials of Antibiotics for Acute Respiratory Infections: Taking Account of Recruitment Exclusion of The Most Ill.
• Retrieval bias in the German dental literature
• Retrieving studies for prognosis systematic reviews
• Retrospective case study to test performance of machine learning: results from Cochrane Heart
• Returning peer reviewer comments for Cochrane protocols and reviews via webinars: A pilot project
• Review authors' views of the PRISMA statement
• Review of Cochrane systematic reviews by medical students: Disseminating information of excellence on evidence-based health
• Review of quality-assessment tools in systematic reviews of cost-effectiveness analyses. Are checklists fit for purpose?
• Review or original article? The manuscript category of systematic review and meta-analysis in high-impact biomedical journals
• Reviewing for cost effectiveness model parameters
• Reviewing outside the office: involving women with young children in systematic reviews
• Reviewing psychometric properties of HRQL measures in mental health: Practical experience
• Reviewing systematic reviews: Can technology boost children’s learning? A meta-analysis of What Works Clearinghouse (WWC) early childhood education programmes
• Reviewing the quantity and quality of evidence available to inform NICE diagnostic guidance. Initial results focusing on end-to-end studies and the implications for Cochrane Reviews
• Reviewing the reviews: the evidence base of contemporary medicine is weak
• Reviews for Africa Programme (RAP): training in the science of research synthesis
• Reviews for Africa Programme: what 3 years of RAPping can do for you!
• Reviews in the area of occupational health and safety literature: results of a four-year pilot
• Reviews in the humanitarian field: adaptation and transparency
• Reviews of effectiveness within a wider world of syntheses of knowledge
• Reviews of parent-child health interventions in public health nursing: a systematic overview
• Reviews with survival from cancer as the primary outcome: writing the protocol
• RevMan 5 for Cochrane Diagnostic test accuracy reviews
• RevMan 5 for Cochrane Intervention review authors - learn to use all the features hands-on.
• RevMan 5 for new and prospective Cochrane authors: learn how to use the software
• RevMan 5 for new and prospective Cochrane authors: learn how to use the software
• RevMan 5 for new and prospective Cochrane Intervention review authors: learn how to use the software
• RevMan 5 presentation for Cochrane Intervention review authors
• RevMan 5.1 for Cochrane intervention review authors: How using all the new features can make life easier
• RevMan 5.2 for Cochrane intervention review authors—how using all the new features can make life easier ***in computer lab; no need for personal laptops
• RevMan 5.3 for experienced Cochrane intervention review authors: learn to use the new features hands-on
• Revolutionizing Systematic Reviews and Meta-analysis with Innovative Software Solutions
• RICE or ice: what does the evidence say? The evidence base for first aid treatment of sprains and strains
• Rigorous and relevant systematic reviews: Lessons learned from mixed-methods approaches in international development 
• Rigorous editorial processes assure high quality products at the Canadian Agency for Drugs and Technologies in Health (CADTH)
• Risk and benefits of pediatric phase I trial in oncology, 2004 through 2014: a systematic review
• Risk assessment of isoflavones in food supplements: a graphical approach to qualitative synthesis
• Risk difference estimation and reporting in systematic reviews
• Risk difference estimation and reporting in systematic reviews
• Risk factors for abstracts falsely excluded during single-reviewer screening – a methods study
• Risk of Bias 2 in Cochrane Intervention Reviews: update on the pilot and implementation in Cochrane
• Risk of Bias 2 tool: the user's point of view
• Risk of bias and applicability assessments for overall prognosis studies (RoB-OPS): Current development status
• Risk of bias and conflict of interest in clinical trials of infant formula
• Risk of bias and data extraction form for prognosis studies
• Risk of bias and PRISMA compliance in systematic reviews of rare disease
• Risk of bias and reporting quality of randomised controlled trials in paediatric pain: a cross-sectional study
• Risk of bias and reporting quality of randomised controlled trials, systematic reviews and meta-analyses in paediatric surgery: a cross-sectional study
• Risk of bias assessment in cross-sectional genetic research: the impact of genetic polymorphisms on methadone response
• Risk of bias assessment in systematic review with network meta-analysis: a meta-research study with AMSTAR-2, ROBIS and the ROB-NMA tool
• Risk of bias assessment of sequence generation: a study of 190 systematic reviews of trials
• Risk of bias assessment of studies included in multiple Cochrane Reviews: agreement between different reviews